Este estudo teve como objetivo identificar perfil sociodemográfico e clínico, história de hospitalizações por Insuficiência Cardí-aca (IC) e seguimento (consultas regulares, tratamento medicamentoso, fatores facilitadores e dificultadores do seguimento) do paciente internado por quadro de descompensação clínica. Foram entrevistados 61 pacientes com idade média de 58,1 (± 15,9) anos, 3,5 (± 4,4) anos de estudo e renda individual de 1,3 (± 2,4) salários-mínimos. A maioria dos sujeitos se encontrava em classe funcional III ou IV da New York Heart Association, tendo como causa mais freqüente de hospitalização, os sinais/sintomas da forma congestiva da IC. 75,4% dos sujeitos relataram acompanhamento clíni-co, porém de periodicidade irregular. Constatou-se utilização de terapêutica medicamentosa em proporção inferior à recomendada pela literatura. Os achados devem auxiliar a identificação dos pacientes com maior risco de descompensação da IC e assim, desenhar e implementar intervenções específicas visando a redução das re-hospitalizações por IC. 
INTRODUCTION
Nowadays, there is a growing number of people afflicted by heart failure (HF). In the United States, one in every three Americans presented a cardiovascular disease, totaling 84,700,000 subjects from 1999 to 2004, five million of these afflicted by HF. After age 65, the incidence of HF approaches 10 cases in every 1000 individuals (1) . In spite of advances in treatment, 300,000 patients die every year (2) . In Brazil, there are no epidemiological studies involving the incidence of HF. However, according to other countries, it is estimated that up to 6.4 million Brazilians suffer from HF. According to data from the SUS (Single Health System -Sistema Único de Saúde) and the Ministry of Health, in the year 2000, approximately 398,000 hospitalizations occurred due to HF, with the occurrence of 26,000 deaths. Nearly one third of hospitalized SUS patients with heart diseases have HF (3) .
One of the greatest problems related to HF evolution regards the high rates of re-hospitalization (4) (5) (6) caused by clinical decompensation. Besides resulting in high costs, these are related to worsening ventricular functions. Studies have shown that each clinical decompensation event results in additional aggravations to the myocardium due to HF remodeling, resulting in a functional degradation of the ventricle and worsening clinical situation (6) .
In Brazil, according to the SUS (7) , approximately 400,000 hospitalizations with a HF diagnosis occurred per year in 1998-2000. The analysis of the period from January 1995 to June 2002 points to a crescent number of cases after the second decade of life, with the numbers increasing twofold from the third to fifth decade, even to the point of growing in the seventh decade, with 466,093 hospitalizations in the period (7) . Re-hospitalizations would be related, firstly, to the existence of flaws in the hospital system itself, and, secondly, to behavioral factors (8) . The following behavioral factors can be mentioned: inadequate compliance with medication, difficulties to modify lifestyle and delays in seeking medical care when the clinical situation worsens (9) . Studies have shown that functional worsening of the NYHA class and the lack of planned follow-ups after the IC diagnosis (10) , as well as compromised quality of life (QL) (11) predict re-hospitalizations within 30 and 60 days, respectively. Therefore, factors that are external to the patient and that contribute to decompensate their clinical situation would include the lack of: documentation of the left ventricular function, continuity of patient monitoring after hospital discharge, successful stabilization of body weight, adequate system for early detection of patients with signs of worsening clinical situations, social support, healthcare education, as well as the incapacity of services to identify individual risks for re-hospitalizations due to non-compliance with the treatment.
Literature notes that half of all hospitalizations could be prevented by continuous clinical monitoring and healthcare education of patients, promoting treatment compliance (9) .
The development and implementation of efficient strategies requires the identification of the particular sociodemographic and clinical profile of patients admitted because of clinical decompensation, which may vary according to region, local socio-cultural characteristics and the availability of healthcare services.
Acting upon the factors related to clinical decompensation requires the work of a multidisciplinary team, due to the complexity of HF patients. The nurse, as a member of the multidisciplinary team, has the role of educator, which requires a precise diagnosis of the magnitude of the factors related to the re-hospitalization problem and its determining factors in order to better implement the educational strategies.
One of the largest teaching hospitals in the state of São Paulo registers a significant number of HF hospitalizations per year, but does not have data about the profile of the patients hospitalized due to clinical decompensation. Therefore, the objective of this study was to identify the sociodemographic and clinical profile, the history of HF hospitalization and outpatient monitoring (regular appointments, drug treatment, facilitating and hindering factors of the treatment) in patients hospitalized with decompensated HF in a teaching hospital in the State of São Paulo.
The data contained in this study should provide support to direct the clinical-educational activities of nurses towards HF patients, aiming to minimize situations of clinical decompensation and their consequent rehospitalizations.
METHOD

Study type
This is a descriptive, exploratory study.
Subjects
Subjects were patients of both genders, admitted due to HF decompensation, in the first 48 hours of hospitalization. Patients who were unable to effectively communicate verbally (due to neurological or psychiatric alterations) and had HF but were hospitalized because of other reasons that were not related to the decompensation were excluded. Sample size (n=61) 
Data collection instrument
The data collection instrument was specifically built for this study and submitted to content validation by three judges with expertise in cardiology and/or experience in the clinical approach of patients with HF. The instrument was divided in four sections: 1.) Sociodemographic characterization -name, age, gender, hometown, education, marital status, people the patient lives with, occupation, individual and family income; 2.) Interview -held in order to obtain the history of hospitalizations due to HF decompensation, information about clinical follow-up, attending pre-scheduled appointments and drug therapy used before the current hospitalization, and associated clinical conditions; 3.) Medical record checking, to obtain information such as etiology and functional classification of the HF before and after the current hospitalization (prescribed during the current hospitalization); 4.) Physical examinationto identify the signs and symptoms of HF decompensation due to the hospitalization and on the day of the interview. The pre-test with five patients with decompensated HF contributed to the final version of the instrument.
Left ventricular hypertrophy (LVH) was assessed based on ecodopplercardiogram data, with the criteria for LVH presence being at least one of the findings: thickness of the myocardial septum or posterior wall of the left ventricle higher or equal to 11 mm, and ventricular mass of 259g for men and 166g for women (12) .
Analysis of the results:
Data were submitted to descriptive statistical analysis, followed by associative tests with Fisher's exact test or chisquare test for categorical variables, and Mann-Whitney's test to compare continuous variables.
The study was approved by the Review Board of Faculdade de Ciências Médicas da UNICAMP (file CEP #233/ 2002). All selected patients signed the consent form.
RESULTS
The 61-patient group had a slight predominance of males (54.1%); average age was 58.1 (±15.8) years and 3.5 (±4.4) years of education. Most subjects had a stable partner (60.6%), 34.4% lived with a spouse or children, 54.1% had no job, with a reported monthly income of 1.36 (±2.4) times the minimum wage (MW) ( Table 1 ).
Only 29.5% (18/61) of the patients had HF hospital records of functional classification (FC) in accordance with NYHA before hospitalization. These 18 patients had been classified in the last clinical evaluation, previous to the hospitalization, such as: FC I: 5.5%; FC II 16.6%; FC III 50.0%; FC IV 27.8%. At the hospitalization, almost all patients (91.8%) were in FC IV.
Among the associated clinical conditions, systemic hypertension (SH) (57.4%; 35/61), heart valve diseases, kidney failure and coronary diseases were frequent, present in similar proportions (31%; 19/61).
Regarding the signs and symptoms resulting from HF, as recorded on the day of hospitalization, the following signs are worth noting: lower limb edema (80.3%), fine rales (75.4%) and hepatomegaly (55.7%). Regarding symptoms, dyspnea (85.2%) stands out ( Table 2 ).
Regarding the signs and symptoms investigated actively by the researcher, the most prevalent symptom was dyspnea (96.7%), followed by fatigue (93.4%), coughing and palpitation, present in equal amounts (46.6%). As for the signs, the fine rales (85.2%) and lower limb edemas (82.0%) were noted ( Table 2 ). The distribution analysis of the signs and symptoms among males and females showed a significantly higher frequency of coughing (p=0.0325 c 2 ) and headaches (p=0.0141c Evidence of structural heart injuries, identified with ecodopplercardiograms, was investigated in 32 patients who performed the exam during hospitalization. The systolic and diastolic diameters of the left ventricle were observed, as well as the left atrium diameter, itself an evidence of structural heart injury, and still a reduced fraction of ejection (FE), characterizing a systolic dysfunction. FE was significantly more compromised among men, regardless of the method employed. (Table 3) . According to the patient, the reason for HF worsening and the consequent necessity of hospitalization was attributed to: the presence of symptoms (27.8%), stressing factors (16.4%), other associated clinical conditions (8.2%), inadequate habits like smoking and unhealthy diet (6.6%). Nearly half of the patients (41.0%) could not identify the reason that led them to decompensation and the need for hospitalization. Regarding the precipitating event of the current hospitalization, the high prevalence of symptoms was observed, noting dyspnea 86.9%, followed by lower limb edemas (55.7%), coughing (24.6%) and abdominal pain (16.4%).
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As for the history of hospitalizations due to HF, most subjects (60.7%) reported previous hospitalizations, with 64.8%
reporting from 1 to 5 previous hospitalizations. The average number of previous hospitalizations was 2.35 (±0.75), with a high variability in the average time between hospitalizations (Table 4) . Although the average time between hospitalizations had been lower among females than among males, this difference was not significant in any period. It was observed that, out of the 46 subjects undergoing clinical monitoring, 84.8% reported that they complied with periodical appointments. The reason these 39 patients most often mentioned to comply with the follow-up appointments was acknowledging the severity of the disease (28.2%), followed by the importance of having easy access to the healthcare service (25.6%), acknowledgment of the importance of the treatment (20.5%) and, less frequently, commitment with the medical team and the desire for a cure.
The most frequent reason for non-compliance among the seven patients was the difficulty to access the healthcare service related to transportation (57.1%), followed by inadequate service provided at the healthcare facility, family problems and forgetfulness, in similar proportions (14.3%).
Of the 15 patients who reported not undergoing monitoring, 73.3% mentioned not knowing about their diagnosis, 20.0% reported problems with the healthcare center that did not refer them to monitoring, being restricted to the emergency appointments, and 6.7% reported family problems.
As for the previous and current therapies used by the patients, diuretics were predominant in 84.9% (45/53) and 93.4% (57/61) of the subjects, respectively. Not all patients use the converting enzyme inhibitor (ACEI). Previous usage is observed in less than half the subjects (60.4%, 32/53), and increasing frequency of use during hospitalization (71.7%; 43/60) ( Table 5 ). 
++
Beta blocker (propranolol and carvedilol);
• Digital (digoxin, digitoxin and cedilanide); Others: anti-emetics, hypoglycemiants, antibiotics, analgesics, antipyretic, statins, neuroleptics, nitrates, antidepressants, bronchodilators, mycophenolates, calcium carbonates, electrolytes, sympathomimetics, antacids and anti-inflammatory agents.
DISCUSSION
Literature (13) (14) notes the influence of low socioeconomic levels, more specifically low income (14) , on the increased risk of re-hospitalizations due to HF. In this study, most patients were characterized by low income and low education, which represents evidence of high risks of re-hospitalization. Another interesting data regards the average age of the patients, which is lower than the average described in international literature, data that was also observed in HF decompensation. In the study comparing results from HF treatment among tertiary hospitals in Brazil and the United States (15) , Brazilians with HF also had lower average ages.
Although 50% of the patients were younger than 60, only 2.6% of them were professionally active. This shows the strong social impact of HF, which removes individuals from the job market who are still in their productive years.
Regarding social and family support, the studied group seems to have advantages that can be explored in nurses' educational activity, since most of them were married, living with a spouse and children and literature has described that HF patients who live alone have worse QoL (16) .
As for the clinical characterization, the complexity of the syndrome is demonstrated by the high co-existence of clinical conditions, the presence of structural heart injuries and LV dysfunction, as well as the history of hospitalizations -average 2.35 per patient, with average intervals between five and nine months.
The associated clinical conditions of the studied patients include SH and coronary disease, which has been associated to worse HF prognostics (6) .
Regarding the signs and symptoms that led to hospitalization, those with the congestive form of HF decompensation are noted, with dyspnea and edema as the most prevalent. At hospitalization, other signs and symptoms were registered, such as rales, hepatomegaly, ascites, noting the prevalence of the congestive form of HF decompensation. According to literature, HF patients who have volume overloads represent the largest share of patients with decompensated HF (6) .
In general, the patients tend to report a gradual beginning of the edema or ascites, increasing symptoms of fatigue or dyspnea and reduction of the basal response to the diuretic. Although these signs are frequent, it is impor-tant to note that, even in the case of a substantial amount of body fluid, as a consequence of the increased venous capacity in these patients, a subgroup of these patients may not present the characteristic signs of congestion. Therefore, other evidence of HF decompensation or risk factors for decompensation should also be investigated.
In a study about the length of each HF symptom experienced by elderly adults until they decide to turn to a hospital emergency service for evaluation, the following reports were observed: dyspnea for an average period of three days, reduced to a 12-hour period if the symptoms were acute (17) . For edemas, weight gain, coughing and fatigue, the average was seven days. Dyspnea is perceived by the patient as more threatening, being probably the most predominant discomfort reported.
It is worth noting, however, that the signs and symptoms were more frequent in this study according to the researcher's assessment. Considering a low likelihood of nearly all the participants presenting worsening situations, after hospitalization, it seems possible that these data were underestimated in the registry performed when the patient was admitted, due to the non-existence of a systematized script for the assessment of patients with HF decompensation, which will direct its systematic investigation and registry, recording the most evident or reported signs. Among the symptoms, there is fatigue, reported in 6.5% of the medical records and by 93.4% of the patients at the moment of the interview.
A previous study notes that fatigue, especially in the elderly, tends to be wrongly interpreted as a result of old age, being underestimated. Another fact worth noting is the early start of the HF decompensation signs and symptoms, which are treated with tolerance by the patients but which, if acknowledged and valorized, could lead to early intervention, avoiding hospitalization.
While literature (17) observes the need to orient the patients to monitor their HF decompensation signs and symptoms, the present study also verified the need for orientation, training and establishment of service standards and registry of healthcare professionals who provide care to these patients, since the inadequate recording of the signs and symptoms does not allow for a global evaluation of the subject that could subsidize their future monitoring.
Structural injuries and dysfunctions in the LV were made evident, highlighting the reduction of FE in the group as a whole and significantly lower among men. Studies (2, 17) have noted the importance of early detection and treatment of ventricular dysfunction, a condition associated to heart remodeling, whose prevention and/or early treatment with the use of ACEI and beta-blockers has a strong impact on QL and survival of the patients with HF. As such, the patients in this study with a preserved ventricular function require special attention in the establishment of the therapeutic strategy, especially in the control of SH and underlying ischemia, which was not observed given the low number of subjects using this medication before hospitalization.
Data showed the lack of regular clinical monitoring when the subject is not hospitalized, considering that, out of 46 patients who reported periodic clinical monitoring, 39 mentioned having appointments regularly, considering only their attendance to the appointments. Therefore, nearly half of the patients did not present regular monitoring, which is indicated as one of the causes of decompensation and re-hospitalization (4, 8) .
Moreover, the place for return appointments after the last hospitalization is noted -which, for most patients, was the hospital (outpatient clinic or emergency service). This situation shows that there is a need for a rational follow-up proposal, which, based on the gravity of the patient's condition, could permit different referrals, early detection and intervention, as well as a periodic evaluation according to the demand of the clinical situation, thus avoiding serious decompensations that lead to hospitalization. Similar data related to the difficulty of clinical follow-up were also evident in a previous study involving hypertensive patients (18) .
In this study, the individual and environmental factors were identified as responsible for non-compliance with treatment or lack of regular follow-up. Access to the healthcare service and the problems that are inherent to the service itself, which result in inadequate treatment according to the patient's perception, need to be revisited. The right to access and good service provision should be guaranteed -and the problem should be discussed not only locally, but it should involve broader healthcare policies, aiming for the recognition of HF as a public healthcare problem that requires specific action at all levels of healthcare services. On an individual basis, educational actions should cover the information given to patients about their condition, gravity, prognosis and the need for regular monitoring, as well as the importance of strategies aimed at overcoming individual barriers for treatment.
The frequency of ACEI and beta-blocker use was inferior to literature recommendations. National and international studies (15, 4) have evidenced the under-utilization of ACEI. Therefore, almost ten years after the indication of the use of ACEI, it can be verified that many patients still lack the benefits of using the two only drugs that, until now, are proven to change the course of HF evolution.
FINAL CONSIDERATIONS
As a final reflection, it should be noted that the findings in this study need to be interpreted carefully, since they were obtained from a small sample size, not representative of a 12-month period. However, the data show that the hospitalized patients presented a large amount of factors that have been associated to HF decompensation and repeated hospitalizations. This is a group that presents clinical complexity, with irregular clinical follow-up and sub-utilization of the recommended drug therapy, indicating the need to design and implement interventions that will al-
